Published in Neurosurg Rev on April 13, 2013
Signaling pathways and the cerebral cavernous malformations proteins: lessons from structural biology. Cell Mol Life Sci (2013) 1.08
Cerebral cavernous malformation proteins at a glance. J Cell Sci (2014) 1.00
A retrospective and consecutive analysis of the epidemiology and management of spinal cavernomas over the last 20 years in a single center. Neurosurg Rev (2015) 0.82
Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1. Free Radic Biol Med (2016) 0.80
Genetics of cerebral cavernous malformations: current status and future prospects. J Neurosurg Sci (2015) 0.76
Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A (1971) 31.05
The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg (1994) 3.06
Cerebral cavernous malformations. Incidence and familial occurrence. N Engl J Med (1988) 2.65
The natural history of cerebral cavernous malformations. J Neurosurg (1995) 2.21
[131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies]. Neurochirurgie (1989) 2.10
Genetics of cavernous angiomas. Lancet Neurol (2007) 2.02
A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells. Hum Mol Genet (2008) 2.02
Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet (2008) 1.95
Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion. Stroke (2005) 1.70
Recent insights into cerebral cavernous malformations: the molecular genetics of CCM. FEBS J (2010) 1.53
Cerebral cavernous malformation: new molecular and clinical insights. J Med Genet (2006) 1.52
A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease. Hum Mol Genet (2010) 1.39
Endothelial proliferation, neoangiogenesis, and potential de novo generation of cerebrovascular malformations. J Neurosurg (2001) 1.22
The epidemiology of multiple births. Hum Reprod Update (1999) 1.13
Cerebral cavernous malformations: somatic mutations in vascular endothelial cells. Neurosurgery (2009) 1.10
Spectrum of genotype and clinical manifestations in cerebral cavernous malformations. Neurosurgery (2006) 1.05
CCM2 gene polymorphisms in Italian sporadic patients with cerebral cavernous malformation: a case-control study. Int J Mol Med (2012) 0.82
Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow. Cell (2008) 2.84
Near-infrared indocyanine green video angiography: a new method for intraoperative assessment of vascular flow. Neurosurgery (2003) 2.66
Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation. Mol Cell Biol (2002) 2.65
Neurofibromin regulation of ERK signaling modulates GABA release and learning. Cell (2008) 2.65
Evaluation of an estrogen receptor-beta agonist in animal models of human disease. Endocrinology (2003) 2.63
Nf1 has an essential role in endothelial cells. Nat Genet (2002) 2.63
Mutations in genes encoding subunits of RNA polymerases I and III cause Treacher Collins syndrome. Nat Genet (2010) 2.52
Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder. Blood (2004) 2.42
Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity. Cancer Res (2003) 2.30
Expression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine model. Cancer Cell (2009) 2.14
A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells. Hum Mol Genet (2008) 2.02
Cavernoma-related epilepsy: review and recommendations for management--report of the Surgical Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia (2013) 2.00
Sentinel headache and the risk of rebleeding after aneurysmal subarachnoid hemorrhage. Stroke (2006) 1.62
Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling. Proc Natl Acad Sci U S A (2010) 1.61
Haploinsufficiency of a spliceosomal GTPase encoded by EFTUD2 causes mandibulofacial dysostosis with microcephaly. Am J Hum Genet (2012) 1.57
Risk of shunt-dependent hydrocephalus after occlusion of ruptured intracranial aneurysms by surgical clipping or endovascular coiling: a single-institution series and meta-analysis. Neurosurgery (2007) 1.57
Deletion of Nf1 in neurons induces increased axon collateral branching after dorsal root injury. J Neurosci (2007) 1.54
The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells. Cancer Cell (2008) 1.54
Cerebral cavernomas in the adult. Review of the literature and analysis of 72 surgically treated patients. Neurosurg Rev (2002) 1.53
Retinal amino acid neurochemistry in health and disease. Clin Exp Optom (2013) 1.51
Molecular classification of low-grade diffuse gliomas. Am J Pathol (2010) 1.51
Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation. Cancer Cell (2008) 1.46
Effective surgical treatment of cerebral cavernous malformations: a multicenter study of 79 pediatric patients. J Neurosurg Pediatr (2011) 1.45
Correlation of screening and confirmatory results in tiered immunogenicity testing by solution-phase bridging assays. J Pharm Biomed Anal (2012) 1.43
Chfr regulates a mitotic stress pathway through its RING-finger domain with ubiquitin ligase activity. Cancer Res (2002) 1.43
Overlapping cortical malformations and mutations in TUBB2B and TUBA1A. Brain (2013) 1.40
Prevalence and nonrandom distribution of exonic mutations in interferon regulatory factor 6 in 307 families with Van der Woude syndrome and 37 families with popliteal pterygium syndrome. Genet Med (2009) 1.38
Comparative pathology of nerve sheath tumors in mouse models and humans. Cancer Res (2004) 1.31
Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex. Hum Mutat (2008) 1.31
An autosomal recessive limb girdle muscular dystrophy (LGMD2) with mild mental retardation is allelic to Walker-Warburg syndrome (WWS) caused by a mutation in the POMT1 gene. Neuromuscul Disord (2005) 1.30
Coil embolization of anterior circulation aneurysms supported by the Solitaire AB Neurovascular Remodeling Device. Neuroradiology (2009) 1.27
FIP200 is required for maintenance and differentiation of postnatal neural stem cells. Nat Neurosci (2013) 1.25
The full spectrum of holoprosencephaly-associated mutations within the ZIC2 gene in humans predicts loss-of-function as the predominant disease mechanism. Hum Mutat (2009) 1.23
WNT10A mutations are a frequent cause of a broad spectrum of ectodermal dysplasias with sex-biased manifestation pattern in heterozygotes. Am J Hum Genet (2009) 1.23
Gene and noncoding RNA regulation underlying photoreceptor protection: microarray study of dietary antioxidant saffron and photobiomodulation in rat retina. Mol Vis (2010) 1.20
ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities. Cell (2012) 1.18
BET bromodomain protein inhibition is a therapeutic option for medulloblastoma. Oncotarget (2013) 1.17
RBX1/ROC1 disruption results in early embryonic lethality due to proliferation failure, partially rescued by simultaneous loss of p27. Proc Natl Acad Sci U S A (2009) 1.16
Waffle-cone technique with Solitaire™ AB remodeling device: endovascular treatment of highly selected complex cerebral aneurysms. Neuroradiology (2010) 1.16
Tie2-Cre-induced inactivation of a conditional mutant Nf1 allele in mouse results in a myeloproliferative disorder that models juvenile myelomonocytic leukemia. Pediatr Res (2004) 1.14
SAG/RBX2/ROC2 E3 ubiquitin ligase is essential for vascular and neural development by targeting NF1 for degradation. Dev Cell (2011) 1.13
Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients. Oncol Rep (2008) 1.11
Mutations in ZIC2 in human holoprosencephaly: description of a novel ZIC2 specific phenotype and comprehensive analysis of 157 individuals. J Med Genet (2009) 1.10
Cyst of the third ventricle as an unusual cause of acquired hydrocephalus. Pediatr Neurol (2003) 1.08
Serum S-100B protein as a molecular marker in severe traumatic brain injury. Restor Neurol Neurosci (2003) 1.04
Clinical progression and genetic analysis in hereditary spastic paraplegia with thin corpus callosum in spastic gait gene 11 (SPG11). Arch Neurol (2004) 1.03
5-(3-Cyclopentyl-2-thioxo-2,3-dihydro-1H-benzimidazol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile: A novel, highly potent, selective, and orally active non-steroidal progesterone receptor agonist. Bioorg Med Chem (2007) 1.02
Influence of hormones and hormone metabolites on the growth of Schwann cells derived from embryonic stem cells and on tumor cell lines expressing variable levels of neurofibromin. Dev Dyn (2008) 1.01
Knockdown of TFPI-2 promotes migration and invasion of glioma cells. Neurosci Lett (2011) 1.01
Alterations in the RB1 pathway in low-grade diffuse gliomas lacking common genetic alterations. Brain Pathol (2011) 1.00
A network of heterochronic genes including Imp1 regulates temporal changes in stem cell properties. Elife (2013) 0.99
Implication of PTEN in production of reactive oxygen species and neuronal death in in vitro models of stroke and Parkinson's disease. Neurochem Int (2006) 0.98
Immunohistochemical study in dural arteriovenous fistulas and possible role of local hypoxia for the de novo formation of dural arteriovenous fistulas. Clin Neurol Neurosurg (2004) 0.97
Enhancement of oral bioavailability of the poorly water-soluble drug silybin by sodium cholate/phospholipid-mixed micelles. Acta Pharmacol Sin (2010) 0.97
Early onset and slow progression of SCA28, a rare dominant ataxia in a large four-generation family with a novel AFG3L2 mutation. Eur J Hum Genet (2010) 0.97
Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations. Neurosurg Focus (2010) 0.97
Prognostic value of choline and creatine in WHO grade II gliomas. Neuroradiology (2008) 0.96
Gene dosage-dependent rescue of HSP neurite defects in SPG4 patients' neurons. Hum Mol Genet (2013) 0.96
ZmCPK11 is involved in abscisic acid-induced antioxidant defence and functions upstream of ZmMPK5 in abscisic acid signalling in maize. J Exp Bot (2012) 0.96
Is the image guidance of ultrasonography beneficial for neurosurgical routine? Surg Neurol (2007) 0.96
Surgical closure and reconstruction of a large occipital encephalocele without parenchymal excision. Childs Nerv Syst (2004) 0.95
Spontaneous cerebellar hemorrhage--experience with 57 surgically treated patients and review of the literature. Neurosurg Rev (2010) 0.95
Image-guided transsylvian, transinsular approach for insular cavernous angiomas. Neurosurgery (2003) 0.95
Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment. Strahlenther Onkol (2006) 0.95
The venous angioarchitecture of sporadic cerebral cavernous malformations: a susceptibility weighted imaging study at 7 T MRI. J Neurol Neurosurg Psychiatry (2012) 0.95
S-100B protein as a serum marker of secondary neurological complications in neurocritical care patients. Neurol Res (2004) 0.95
Microcephaly, microtia, preauricular tags, choanal atresia and developmental delay in three unrelated patients: a mandibulofacial dysostosis distinct from Treacher Collins syndrome. Am J Med Genet A (2009) 0.95
Intraoperative ultrasound assistance in treatment of intradural spinal tumours. Clin Neurol Neurosurg (2011) 0.94
Magnetic and highly recyclable macroporous carbon nanotubes for spilled oil sorption and separation. ACS Appl Mater Interfaces (2013) 0.94
Neuroform stent-assisted treatment of intracranial aneurysms: long-term follow-up study of aneurysm recurrence and in-stent stenosis rates. Neuroradiology (2013) 0.94
Familial cardiac valvulopathy due to filamin A mutation. Am J Med Genet A (2011) 0.93
CCM1 gene deletion identified by MLPA in cerebral cavernous malformation. Neurosurg Rev (2006) 0.93
Thirty-two new cases with small supernumerary marker chromosomes detected in connection with fertility problems: detailed molecular cytogenetic characterization and review of the literature. Int J Mol Med (2008) 0.93
Frequent BRAF gain in low-grade diffuse gliomas with 1p/19q loss. Brain Pathol (2012) 0.92
WGS catalysis and in situ studies of CoO(1-x), PtCo(n)/Co3O4, and Pt(m)Co(m')/CoO(1-x) nanorod catalysts. J Am Chem Soc (2013) 0.92
Transplantation of vascular endothelial growth factor-transfected neural stem cells into the rat brain provides neuroprotection after transient focal cerebral ischemia. Neurosurgery (2005) 0.92
Subarachnoid hemorrhage and intracerebral hematoma: incidence, prognostic factors, and outcome. Neurosurgery (2008) 0.92
Loss of CCM3 impairs DLL4-Notch signalling: implication in endothelial angiogenesis and in inherited cerebral cavernous malformations. J Cell Mol Med (2013) 0.92
Transsulcal approach supported by navigation-guided neurophysiological monitoring for resection of paracentral cavernomas. Clin Neurol Neurosurg (2008) 0.91
GSK3β is a checkpoint for TNF-α-mediated impaired osteogenic differentiation of mesenchymal stem cells in inflammatory microenvironments. Biochim Biophys Acta (2013) 0.90
SAR studies of 6-(arylamino)-4,4-disubstituted-1-methyl-1,4-dihydro-benzo[d][1,3]oxazin-2-ones as progesterone receptor antagonists. Bioorg Med Chem Lett (2006) 0.90
Caudal image contrast inversion in MPRAGE at 7 Tesla: problem and solution. Acad Radiol (2011) 0.90
Ascending colon adenocarcinoma with tonsillar metastasis: a case report and review of the literature. World J Gastroenterol (2008) 0.90
Seventy-two-hour release formulation of the poorly soluble drug silybin based on porous silica nanoparticles: in vitro release kinetics and in vitro/in vivo correlations in beagle dogs. Eur J Pharm Sci (2012) 0.89
Cancer subtype discovery and biomarker identification via a new robust network clustering algorithm. PLoS One (2013) 0.89
Susceptibility weighted magnetic resonance imaging of cerebral cavernous malformations: prospects, drawbacks, and first experience at ultra-high field strength (7-Tesla) magnetic resonance imaging. Neurosurg Focus (2010) 0.89
Homozygous dystroglycan mutation associated with a novel muscle-eye-brain disease-like phenotype with multicystic leucodystrophy. Neurogenetics (2013) 0.88
Genotypic and phenotypic analysis of 396 individuals with mutations in Sonic Hedgehog. J Med Genet (2012) 0.88
Pancreatic-derived factor (FAM3B), a novel islet cytokine, induces apoptosis of insulin-secreting beta-cells. Diabetes (2003) 0.88
Clinical impact of CCM mutation detection in familial cavernous angioma. Childs Nerv Syst (2006) 0.88
Familial West syndrome and dystonia caused by an Aristaless related homeobox gene mutation. Eur J Pediatr (2005) 0.88
Management and outcome of patients with acute traumatic subdural hematomas and pre-injury oral anticoagulation therapy. Neurol Res (2009) 0.88
(1)H MRSI and progression-free survival in patients with WHO grades II and III gliomas. Neurol Res (2009) 0.88
Intraoperative ultrasound to define focal cortical dysplasia in epilepsy surgery. Epilepsia (2007) 0.88